News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Puts Cell Therapeutics, Inc. (CTIC) Blood Cancer Drug on Hold After Death


6/24/2013 8:01:17 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cell Therapeutics Inc said the U.S. Food and Drug Administration has placed a partial clinical hold on the company's experimental blood cancer drug after the death of a patient. The patient, being treated with the drug tosedostat in combination with a chemotherapy drug, died of myocarditis, or infection of the heart muscle, the company said in a regulatory filing on Monday.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Street Insider

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES